Pregled bibliografske jedinice broj: 726965
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer // Journal of geriatric oncology, 4 (2013), 4; 346-352 doi:10.1016/j.jgo.2013.07.006 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 726965 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
Autori
Vahdat, L.T. ; Vrdoljak, Eduard ; Gómez, H. ; Li, R.K. ; Bosserman, L. ; Sparano, J.A. ; Baselga, J. ; Mukhopadhyay, P. ; Valero, V.
Izvornik
Journal of geriatric oncology (1879-4068) 4
(2013), 4;
346-352
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
metastatic breast cancer
Sažetak
Data on chemotherapy regimens in elderly patients with metastatic breast cancer (MBC) are limited. The aim of this retrospective pooled analysis was to determine efficacy and safety of ixabepilone plus capecitabine versus capecitabine alone in patients with MBC aged ≥ 65 years.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
